These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 21287763)
21. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction. Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702 [No Abstract] [Full Text] [Related]
22. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients. Walter M; Wiesbeck GA; Degen B; Albrich J; Oppel M; Schulz A; Schächinger H; Dürsteler-MacFarland KM Addict Biol; 2011 Jan; 16(1):145-51. PubMed ID: 20331562 [TBL] [Abstract][Full Text] [Related]
23. From illegal poison to legal medicine: a qualitative research in a heroin-prescription trial in Spain. Romo N; Poo M; Ballesta R; Drug Alcohol Rev; 2009 Mar; 28(2):186-95. PubMed ID: 19320704 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial. Blanken P; Hendriks VM; Huijsman IA; van Ree JM; van den Brink W Drug Alcohol Depend; 2016 Jul; 164():55-63. PubMed ID: 27177805 [TBL] [Abstract][Full Text] [Related]
26. Is there a need for heroin substitution treatment in Vancouver's Downtown Eastside? Yes there is, and in many other places too. Schechter MT; Kendall P Can J Public Health; 2011; 102(2):87-9. PubMed ID: 21608377 [TBL] [Abstract][Full Text] [Related]
27. Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial. Eiroa-Orosa FJ; Haasen C; Verthein U; Dilg C; Schäfer I; Reimer J Drug Alcohol Depend; 2010 Dec; 112(3):226-33. PubMed ID: 20708349 [TBL] [Abstract][Full Text] [Related]
28. Feasibility of double-blind clinical trials with oral diacetylmorphine: a randomized controlled phase II study in an inpatient setting. Colom Farran J; Casas M; Pérez de Los Cobos J; Del Río M; Roncero C; Castells X; Valero S; Eiroa-Orosa FJ; Batlle F; Trujols J Eur Addict Res; 2012; 18(6):279-87. PubMed ID: 22854605 [TBL] [Abstract][Full Text] [Related]
30. The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review. F Martins ML; Wilthagen EA; Oviedo-Joekes E; Beijnen JH; de Grave N; Uchtenhagen A; Beck T; Van den Brink W; Schinkel AH Drug Alcohol Depend; 2021 Oct; 227():108984. PubMed ID: 34482044 [TBL] [Abstract][Full Text] [Related]
31. Treating heroin addiction: bridging the past and future--a Malaysian experience. Robson N; Rashid R; Nazar M; Habil H Asia Pac Psychiatry; 2015 Mar; 7(1):121-5. PubMed ID: 23857876 [No Abstract] [Full Text] [Related]
32. Prescription of heroin to treatment resistant heroin addicts: double blinding is not possible. Dehue T BMJ; 2004 Jan; 328(7433):228; author reply 229. PubMed ID: 14739203 [No Abstract] [Full Text] [Related]
33. Prescription of heroin to treatment resistant heroin addicts: replacement therapies need to be tested on a level playing field. Reed LJ; de Wet C; Bearn J BMJ; 2004 Jan; 328(7433):228; author reply 229. PubMed ID: 14739205 [No Abstract] [Full Text] [Related]
34. Heroin-assisted treatment in the Netherlands: History, findings, and international context. Blanken P; van den Brink W; Hendriks VM; Huijsman IA; Klous MG; Rook EJ; Wakelin JS; Barendrecht C; Beijnen JH; van Ree JM Eur Neuropsychopharmacol; 2010 Apr; 20 Suppl 2():S105-58. PubMed ID: 20362236 [TBL] [Abstract][Full Text] [Related]
35. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Strang J; Metrebian N; Lintzeris N; Potts L; Carnwath T; Mayet S; Williams H; Zador D; Evers R; Groshkova T; Charles V; Martin A; Forzisi L Lancet; 2010 May; 375(9729):1885-95. PubMed ID: 20511018 [TBL] [Abstract][Full Text] [Related]
36. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study. Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836 [TBL] [Abstract][Full Text] [Related]
37. [Heroin prescribing: Is there scientific evidence of its efficacy for the treatment of its dependence?]. Haro G; Martínez-Raga J; Castellano M; Bolinches F; de Vicente P; Valderrama JC Actas Esp Psiquiatr; 2001; 29(5):343-8. PubMed ID: 11602093 [TBL] [Abstract][Full Text] [Related]
38. [Methadone substitution treatment for heroin addiction: a program assessment in Colombia]. Zapata MA; Giraldo LF Adicciones; 2012; 24(1):69-75. PubMed ID: 22508019 [TBL] [Abstract][Full Text] [Related]
39. The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study. Nosyk B; Geller J; Guh DP; Oviedo-Joekes E; Brissette S; Marsh DC; Schechter MT; Anis AH Drug Alcohol Depend; 2010 Sep; 111(1-2):161-5. PubMed ID: 20510549 [TBL] [Abstract][Full Text] [Related]
40. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. van den Brink W; Hendriks VM; Blanken P; Koeter MW; van Zwieten BJ; van Ree JM BMJ; 2003 Aug; 327(7410):310. PubMed ID: 12907482 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]